2023 - Research.com Biology and Biochemistry in United States Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Biology and Biochemistry in United States Leader Award
2005 - Member of the National Academy of Sciences
2002 - Member of the National Academy of Medicine (NAM)
1999 - Fellow of the American Academy of Arts and Sciences
Member of the Association of American Physicians
His primary areas of investigation include Cell biology, Apoptosis, Biochemistry, Programmed cell death and Molecular biology. His Cell biology research is multidisciplinary, incorporating elements of Autophagy, Bcl-2 family and Bcl-2-associated X protein. Craig B. Thompson focuses mostly in the field of Apoptosis, narrowing it down to matters related to Cell culture and, in some cases, Cancer research and Gene product.
In his research, BCL-2 Gene Family is intimately related to Transfection, which falls under the overarching field of Programmed cell death. Craig B. Thompson interconnects Gene expression, CD28, T cell, Cytochrome c and CD3 in the investigation of issues within Molecular biology. His CD28 study which covers IL-2 receptor that intersects with Interleukin 21.
Craig B. Thompson mainly focuses on Cell biology, Molecular biology, Apoptosis, T cell and Programmed cell death. The Cell biology study combines topics in areas such as Receptor, Biochemistry and Cell growth. As a part of the same scientific study, Craig B. Thompson usually deals with the Molecular biology, concentrating on Gene expression and frequently concerns with Regulation of gene expression.
His Apoptosis research is multidisciplinary, incorporating perspectives in Cell culture, Transfection and Cancer research. Bcl-2 family is the focus of his Programmed cell death research. His studies in Signal transduction integrate themes in fields like Kinase and Intracellular.
Craig B. Thompson spends much of his time researching Cell biology, Biochemistry, Cancer research, Cancer cell and Glutamine. Particularly relevant to Signal transduction is his body of work in Cell biology. His studies deal with areas such as Leukemia, Epigenetics, Mutant and Stem cell as well as Cancer research.
His Mutant research is multidisciplinary, relying on both Biomarker and Molecular biology. Craig B. Thompson interconnects Tumor microenvironment, Glycolysis and Pinocytosis in the investigation of issues within Cancer cell. His research in Glutamine intersects with topics in Cell, Asparagine, Cell culture and Citric acid cycle.
Craig B. Thompson mostly deals with Cell biology, Biochemistry, Glutamine, Metabolism and Cancer cell. His work carried out in the field of Cell biology brings together such families of science as Autophagy, Cancer and Cell growth. The various areas that Craig B. Thompson examines in his Glutamine study include Extracellular, Cell culture, Citrate synthase and In vivo.
His Metabolism course of study focuses on PI3K/AKT/mTOR pathway and Carnitine O-palmitoyltransferase, Warburg effect and AMP-activated protein kinase. Morphogenesis, Reprogramming and Embryonic stem cell is closely connected to Tumor microenvironment in his research, which is encompassed under the umbrella topic of Cancer cell. The concepts of his Signal transduction study are interwoven with issues in Mitochondrion and Effector.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden;Lewis C. Cantley;Craig B. Thompson.
Science (2009)
Apoptosis in the pathogenesis and treatment of disease
Craig B. Thompson.
Science (1995)
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham.
Autophagy (2012)
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Michael C. Wei;Wei-Xing Zong;Emily H.-Y. Cheng;Tullia Lindsten.
Science (2001)
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
Lawrence H. Boise;Maribel González-García;Christina E. Postema;Liyun Ding.
Cell (1993)
THE BIOLOGY OF CANCER: METABOLIC REPROGRAMMING FUELS CELL GROWTH AND PROLIFERATION
Ralph J. DeBerardinis;Julian J. Lum;Georgia Hatzivassiliou;Craig B. Thompson.
Cell Metabolism (2008)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang;David W. White;Stefan Gross;Bryson D. Bennett.
Nature (2009)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Tilman Oltersdorf;Steven W. Elmore;Alexander R. Shoemaker;Robert C. Armstrong.
Nature (2005)
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Paul Waterhouse;Josef M. Penninger;Emma Timms;Andrew Wakeham.
Science (1995)
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Daniel J. Klionsky;Hagai Abeliovich;Patrizia Agostinis;Devendra K. Agrawal.
Autophagy (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Memorial Sloan Kettering Cancer Center
University of Pennsylvania
Emory University
Hong Kong Polytechnic University
Rutgers, The State University of New Jersey
Harvard University
Vanderbilt University Medical Center
The University of Texas Southwestern Medical Center
Princeton University
INSEAD
University of Naples Federico II
George Washington University
Stanford University
Radboud University Nijmegen
Université Catholique de Louvain
University of Melbourne
University of Tübingen
University of Queensland
University of Lisbon
New Jersey Institute of Technology
University of Montreal
University of British Columbia
University of Missouri–Kansas City
University of Science and Technology of China
University of Wisconsin–Madison